Back

Restoring hippocampal sharp-wave ripples under glutamate transporter dysfunction

Gao, Y.; Zhou, Z.; Wu, J.-y.

2026-05-29 neuroscience
10.64898/2026.05.28.728386 bioRxiv
Show abstract

Disruption of glutamate homeostasis is believed to contribute to the early progression of Alzheimers disease (AD) and associated neurodegeneration. Soluble amyloid-{beta} oligomers impair excitatory amino acid transporters (EAATs), reducing glutamate clearance, while also enhancing glutamate release from neurons and astrocytes. Together, these effects produce persistent glutamatergic dysregulation that disrupts synaptic and network function. Here, we asked whether the effects of EAAT attenuation can be mitigated through ion-channel modulation. TBOA, a selective EAAT inhibitor, was used to model early-stage glutamatergic dysregulation. TBOA reduced the local field potential amplitude of hippocampal sharp-wave ripples (SWRs) in mouse hippocampal slices, suggesting that glutamate accumulation disrupts network synchrony. Calcium imaging further showed that TBOA diminished SWR-associated population calcium transients while promoting spontaneous calcium transients in individual neurons, indicating a shift from coordinated population activity toward disorganized cellular activity. KCNQ-channel openers ML213 and ICA-27243 partially restored the TBOA-induced decline in SWR amplitude. In contrast, similar restorative effects were not observed following modulation of other ion channels, including blockade of AMPA and NMDA receptors or HCN/Ih channels, or activation of large-conductance Ca2+-activated K+ (BK) channels and G-protein-activated inwardly rectifying potassium (GIRK) channels. Together, these findings suggest that KCNQ-channel openers may occupy a unique position in mitigating glutamate-related hyperexcitability during early AD-associated network dysfunction.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.2%
14.6%
2
Alzheimer's & Dementia
143 papers in training set
Top 0.6%
12.3%
3
Frontiers in Aging Neuroscience
67 papers in training set
Top 0.5%
6.3%
4
Molecular Psychiatry
242 papers in training set
Top 0.4%
6.3%
5
Brain
154 papers in training set
Top 2%
3.6%
6
Alzheimer's Research & Therapy
52 papers in training set
Top 0.7%
3.6%
7
iScience
1063 papers in training set
Top 8%
2.6%
8
Experimental Neurology
57 papers in training set
Top 0.4%
2.3%
50% of probability mass above
9
Acta Neuropathologica Communications
81 papers in training set
Top 0.4%
2.3%
10
Advanced Science
249 papers in training set
Top 8%
2.3%
11
eLife
5422 papers in training set
Top 36%
2.1%
12
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.5%
1.7%
13
Progress in Neurobiology
41 papers in training set
Top 0.8%
1.7%
14
Translational Psychiatry
219 papers in training set
Top 3%
1.7%
15
Annals of Neurology
57 papers in training set
Top 1%
1.5%
16
Journal of Neuroinflammation
50 papers in training set
Top 0.6%
1.3%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 37%
1.3%
18
Neurobiology of Aging
95 papers in training set
Top 2%
1.3%
19
The Journal of Neuroscience
928 papers in training set
Top 6%
1.3%
20
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.2%
21
Nature Communications
4913 papers in training set
Top 57%
1.2%
22
ACS Chemical Neuroscience
60 papers in training set
Top 2%
1.2%
23
Cell Reports
1338 papers in training set
Top 28%
1.2%
24
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.2%
25
Molecular Neurodegeneration
49 papers in training set
Top 0.7%
1.1%
26
Journal of Neurochemistry
50 papers in training set
Top 0.4%
0.9%
27
Scientific Reports
3102 papers in training set
Top 71%
0.9%
28
Journal of Alzheimer's Disease
43 papers in training set
Top 1%
0.8%
29
Molecular Neurobiology
50 papers in training set
Top 1%
0.7%
30
Science Advances
1098 papers in training set
Top 30%
0.7%